(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are PROACTIS SA, GENSIGHT BIOLOGICS, and ABIONYX PHARMA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| PROACTIS SA (PROAC.PA) | 0.11 | 29.76% | 2023-05-11 11:01:49 |
| GENSIGHT BIOLOGICS (SIGHT.PA) | 0.99 | 23.63% | 2023-05-11 08:49:42 |
| ABIONYX PHARMA (ABNX.PA) | 1.99 | 14.01% | 2023-05-11 11:45:39 |
| METABOLIC EXPLORER (METEX.PA) | 1.08 | 11.83% | 2023-05-11 11:00:24 |
| MEDIA 6 (EDI.PA) | 10.00 | 11.11% | 2023-05-11 08:00:11 |
| SOC FRANC CASINOS (SFCA.PA) | 1.98 | 10% | 2023-05-11 11:03:15 |
| FINANCIERE MARJOS (FINM.PA) | 0.11 | 9.9% | 2023-05-11 08:48:58 |
| ITERA (ITERA.OL) | 15.55 | 9.89% | 2023-05-11 11:33:55 |
| SALMAR (SALM.OL) | 478.00 | 8.44% | 2023-05-11 11:59:20 |
| BENETEAU (BEN.PA) | 16.44 | 8.3% | 2023-05-11 11:46:01 |
The three biggest losers today are PHARMING GROUP, BEAULIEU-AV. CERT, and CLARANOVA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| PHARMING GROUP (PHARM.AS) | 1.03 | -12.99% | 2023-05-11 11:03:49 |
| BEAULIEU-AV. CERT (BEAB.BR) | 4.32 | -9.24% | 2023-05-11 11:05:44 |
| CLARANOVA (CLA.PA) | 2.18 | -8.79% | 2023-05-11 11:49:16 |
| ENVIPCO (ENVI.AS) | 2.52 | -8.03% | 2023-05-11 11:02:01 |
| FERMENTALG (FALG.PA) | 0.89 | -7.91% | 2023-05-11 08:48:45 |
| NEPI ROCKCASTLE (NRP.AS) | 5.55 | -7.5% | 2023-05-11 08:03:20 |
| VIVORYON (VVY.AS) | 17.78 | -7.01% | 2023-05-11 11:05:04 |
| CROSSWOOD (CROS.PA) | 13.80 | -6.76% | 2023-05-11 08:47:06 |
| ALFEN (ALFEN.AS) | 72.86 | -5.96% | 2023-05-11 11:00:23 |
| PETROLIA (PSE.OL) | 3.66 | -5.67% | 2023-05-11 08:32:26 |
Winners today
1. PROACTIS SA (PROAC.PA)
29.76% Price Change
Proactis SA provides source-to-pay software solution. It operates software platform that will give control over business spend. It also offers procurement solutions that provide purchasing professionals with the tools they need for purchasing process for routine goods and services, capital goods, and major projects. In addition, it offers invoice capture services, system administration, supplier onboarding, and tail spent management services. Further, Its solutions integrate with various ERP or financial systems. The company was formerly known as HUBWOO and changed its name to Proactis SA in January 2019. The company is based in Suresnes, France. Proactis SA operates as a subsidiary of Proactis Euro Hedgeco Limited.
CAC 40 ended the session with PROACTIS SA jumping 29.76% to €0.11 on Thursday, after three successive sessions in a row of losses. CAC 40 rose 0.28% to €7,381.78, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Yearly Top and Bottom Value
PROACTIS SA’s stock is valued at €0.11 at 22:40 EST, way below its 52-week high of €0.15 and way above its 52-week low of €0.08.
More news about PROACTIS SA.
2. GENSIGHT BIOLOGICS (SIGHT.PA)
23.63% Price Change
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.
CAC 40 ended the session with GENSIGHT BIOLOGICS jumping 23.63% to €0.99 on Thursday while CAC 40 rose 0.28% to €7,381.78.
Earnings Per Share
As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.58.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENSIGHT BIOLOGICS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for GENSIGHT BIOLOGICS is 1513370 which is 324.13% above its average volume of 356809.
More news about GENSIGHT BIOLOGICS.
3. ABIONYX PHARMA (ABNX.PA)
14.01% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA jumping 14.01% to €1.99 on Thursday while CAC 40 jumped 0.28% to €7,381.78.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.7%.
More news about ABIONYX PHARMA.
4. METABOLIC EXPLORER (METEX.PA)
11.83% Price Change
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
CAC 40 ended the session with METABOLIC EXPLORER jumping 11.83% to €1.08 on Thursday while CAC 40 jumped 0.28% to €7,381.78.
Earnings Per Share
As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.78.
Volatility
METABOLIC EXPLORER’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.95%, a negative 0.73%, and a positive 2.68%.
METABOLIC EXPLORER’s highest amplitude of average volatility was 3.72% (last week), 2.17% (last month), and 2.68% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, METABOLIC EXPLORER’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth declined by 26.9%, now sitting on 228.15M for the twelve trailing months.
Yearly Top and Bottom Value
METABOLIC EXPLORER’s stock is valued at €1.08 at 22:40 EST, way below its 52-week high of €5.05 and way above its 52-week low of €0.90.
More news about METABOLIC EXPLORER.
5. MEDIA 6 (EDI.PA)
11.11% Price Change
Groupe MEDIA 6, a point-of-purchase (POP) advertising company, provides multi-material solutions in France and internationally. The company offers hydro-alcoholic gel dispensing column with PMR access options, counter displays, plexiglass protective barriers, protective visors, and floor markings; merchandising management services; point-of-purchase marketing; installs furniture, shop windows, podiums, and communication materials; and processes cardboard, wood, metal, and plastic products. It also provides experiential marketing, POP displays, shop fixtures, shop fittings, pharmacy fittings, trade marketing, and POP display for coloration, as well as operates art workshop. In addition, it offers various tools for the customization of sales accessories, product racks, bag and shoe doors, presentation trays, articulated hands, wooden feet and head, and busts and displays for shops. The company was founded in 1977 and is based in Tremblay-en-France, France. Groupe MEDIA 6 is a subsidiary of VASCO SARL.
CAC 40 ended the session with MEDIA 6 jumping 11.11% to €10.00 on Thursday while CAC 40 jumped 0.28% to €7,381.78.
Earnings Per Share
As for profitability, MEDIA 6 has a trailing twelve months EPS of €0.18.
PE Ratio
MEDIA 6 has a trailing twelve months price to earnings ratio of 55.56. Meaning, the purchaser of the share is investing €55.56 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.87%.
Yearly Top and Bottom Value
MEDIA 6’s stock is valued at €10.00 at 22:40 EST, under its 52-week high of €11.10 and way above its 52-week low of €7.55.
Volume
Today’s last reported volume for MEDIA 6 is 177 which is 2428.57% above its average volume of 7.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.5%, now sitting on 82.91M for the twelve trailing months.
Moving Average
MEDIA 6’s worth is way higher than its 50-day moving average of €8.67 and higher than its 200-day moving average of €9.49.
More news about MEDIA 6.
6. SOC FRANC CASINOS (SFCA.PA)
10% Price Change
Société Française de Casinos Société Anonyme operates casinos in France. The company is also involved in the hotel and restaurant activities. The company is based in Paris, France.
CAC 40 ended the session with SOC FRANC CASINOS rising 10% to €1.98 on Thursday, after two consecutive sessions in a row of losses. CAC 40 rose 0.28% to €7,381.78, after two sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, SOC FRANC CASINOS has a trailing twelve months EPS of €0.3.
PE Ratio
SOC FRANC CASINOS has a trailing twelve months price to earnings ratio of 6.6. Meaning, the purchaser of the share is investing €6.6 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.61%.
More news about SOC FRANC CASINOS.
7. FINANCIERE MARJOS (FINM.PA)
9.9% Price Change
Financière Marjos SA, together with its subsidiaries, engages in the creation, installation, acquisition, and operation of various companies in France and internationally. The company's portfolio includes manufacturing, sales, rental, and maintenance companies. The company was formerly known as Clayeux SA and changed its name to Financière Marjos SA. The company is headquartered in Paris, France.
CAC 40 ended the session with FINANCIERE MARJOS jumping 9.9% to €0.11 on Thursday, after two sequential sessions in a row of losses. CAC 40 rose 0.28% to €7,381.78, after two successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, FINANCIERE MARJOS has a trailing twelve months EPS of €-3.71.
More news about FINANCIERE MARJOS.
8. ITERA (ITERA.OL)
9.89% Price Change
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ITERA jumping 9.89% to €15.55 on Thursday, after three successive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.21% to €1,201.49, following the last session’s upward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.77.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 20.19. Meaning, the purchaser of the share is investing kr20.19 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 27, 2022, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 1.49%.
More news about ITERA.
9. SALMAR (SALM.OL)
8.44% Price Change
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, processing, and selling farmed salmon. The company sells its products through in-house salesforce and/or through close partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Oslo Børs Benchmark Index_GI ended the session with SALMAR rising 8.44% to €478.00 on Thursday while Oslo Børs Benchmark Index_GI dropped 0.21% to €1,201.49.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr26.69.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 17.91. Meaning, the purchaser of the share is investing kr17.91 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.
More news about SALMAR.
10. BENETEAU (BEN.PA)
8.3% Price Change
Bénéteau S.A. designs, manufactures, and sells boats and leisure homes in France and internationally. It provides boats under the Beneteau, Jeanneau, Lagoon, Prestige, Monte Carlo Yachts, Four Winns, Glastron, Scarab, WellCraft, EXCESS, and Delphia brand names; and leisure homes under the IRM, O'HARA, and Coco Sweet brand names. The company also offers bandofbaots.com, a community services platform for purchase and sale of new or used boats; lease purchase, credit, and insurance services through SGB Finance; and inventory and retail finance solutions. Bénéteau S.A. was founded in 1884 and is headquartered in Saint Gilles Croix de Vie, France.
CAC 40 ended the session with BENETEAU rising 8.3% to €16.44 on Thursday, following the last session’s downward trend. CAC 40 jumped 0.28% to €7,381.78, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, BENETEAU has a trailing twelve months EPS of €1.21.
PE Ratio
BENETEAU has a trailing twelve months price to earnings ratio of 13.59. Meaning, the purchaser of the share is investing €13.59 for every euro of annual earnings.
More news about BENETEAU.
Losers Today
1. PHARMING GROUP (PHARM.AS)
-12.99% Price Change
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
AEX-Index ended the session with PHARMING GROUP falling 12.99% to €1.03 on Thursday while AEX-Index rose 0.38% to €751.12.
Earnings Per Share
As for profitability, PHARMING GROUP has a trailing twelve months EPS of €0.02.
PE Ratio
PHARMING GROUP has a trailing twelve months price to earnings ratio of 51.25. Meaning, the purchaser of the share is investing €51.25 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PHARMING GROUP’s stock is considered to be oversold (<=20).
More news about PHARMING GROUP.
2. BEAULIEU-AV. CERT (BEAB.BR)
-9.24% Price Change
Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with BEAULIEU-AV. CERT sliding 9.24% to €4.32 on Thursday while BEL 20 jumped 0.06% to €3,739.83.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEAULIEU-AV. CERT’s stock is considered to be overbought (>=80).
More news about BEAULIEU-AV. CERT.
3. CLARANOVA (CLA.PA)
-8.79% Price Change
Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things businesses in the United States, the United Kingdom, Germany, France, other European countries, and internationally. It operates through three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers FreePrints Photobooks; FreePrints photo tiles for wall decorations; FreePrints cards; FreePrints gifts and Personal Creations for personalized gifts; SimplytoImpress; and CafePress and Gifts.com websites. The Avanquest segment provides the antivirus, ad blocker, cleaning, and optimization tools sold under the Adaware brand; document management tools under the SodaPDF brand name; and photo editor software and apps under the inPixio brand. The myDevices segment offers myDevices, an application platform that provides a range of IoT solutions for the management of assets. It also provides SignPDF, a new digital signature solution. The company was formerly known as Avanquest S.A. and changed its name to Claranova S.E. in June 2017. Claranova SE was incorporated in 1984 and is headquartered in La Garenne-Colombes, France.
CAC 40 ended the session with CLARANOVA dropping 8.79% to €2.18 on Thursday while CAC 40 rose 0.28% to €7,381.78.
Earnings Per Share
As for profitability, CLARANOVA has a trailing twelve months EPS of €-0.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -143.31%.
Volume
Today’s last reported volume for CLARANOVA is 223762 which is 97.16% above its average volume of 113487.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 508.5M for the twelve trailing months.
Moving Average
CLARANOVA’s value is way above its 50-day moving average of €1.98 and way below its 200-day moving average of €2.61.
More news about CLARANOVA.
4. ENVIPCO (ENVI.AS)
-8.03% Price Change
Envipco Holding N.V., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (RVM) for the collection and processing of used beverage containers primarily in the North America and Europe. The company provides technical support, RVM maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. It also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. In addition, the company provides materials handling services primarily in the northeastern part of the United States. Envipco Holding N.V. was incorporated in 1998 and is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with ENVIPCO dropping 8.03% to €2.52 on Thursday, after five successive sessions in a row of losses. AEX-Index jumped 0.38% to €751.12, after two successive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ENVIPCO has a trailing twelve months EPS of €-0.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.56%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENVIPCO’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
ENVIPCO’s stock is valued at €2.52 at 22:40 EST, way under its 52-week high of €3.65 and way higher than its 52-week low of €2.20.
Volatility
ENVIPCO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.16%, a negative 0.31%, and a positive 3.24%.
ENVIPCO’s highest amplitude of average volatility was 2.16% (last week), 4.60% (last month), and 3.24% (last quarter).
Sales Growth
ENVIPCO’s sales growth for the current quarter is 53.7%.
More news about ENVIPCO.
5. FERMENTALG (FALG.PA)
-7.91% Price Change
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.
CAC 40 ended the session with FERMENTALG falling 7.91% to €0.89 on Thursday, following the last session’s downward trend. CAC 40 jumped 0.28% to €7,381.78, after two consecutive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.28.
Volatility
FERMENTALG’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.48%, a negative 0.10%, and a positive 2.81%.
FERMENTALG’s highest amplitude of average volatility was 5.73% (last week), 3.69% (last month), and 2.81% (last quarter).
Volume
Today’s last reported volume for FERMENTALG is 292449 which is 375.96% above its average volume of 61443.
More news about FERMENTALG.
6. NEPI ROCKCASTLE (NRP.AS)
-7.5% Price Change
NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (CEE), with presence in nine countries and an investment portfolio of €5.8 billion as at 31 December 2021. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. Geographically diverse management skills allow NEPI Rockcastle to pursue CEE property opportunities efficiently, benefiting from a strategic advantage in the acquisition, development and management of properties. NEPI Rockcastle owns and operates 52 retail properties (excluding joint venture) which attracted 244 million visits in 2021 (325 million visits in 2019). With group-level management of tenant relationships and a focus on cross-country collaboration, the Group is the leading strategic partner for major retailers targeting CEE countries. The Group's financial strategy includes maintaining a profile of adequate liquidity, conservative gearing, and a diverse debt structure, which combines secured and unsecured bank debt with unsecured bonds listed on the Irish Stock Exchange. NEPI Rockcastle is investment-grade rated by Standard & Poor's (BBB, stable outlook) and Fitch (BBB, positive outlook). NEPI Rockcastle's shares are listed on the Johannesburg Stock Exchange (“JSE”), Euronext Amsterdam (“Euronext”) and A2X. The Group voluntarily distributes at least 90% of its distributable earnings on a semi-annual basis.
AEX-Index ended the session with NEPI ROCKCASTLE sliding 7.5% to €5.55 on Thursday, after two sequential sessions in a row of losses. AEX-Index rose 0.38% to €751.12, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.72.
PE Ratio
NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 7.71. Meaning, the purchaser of the share is investing €7.71 for every euro of annual earnings.
More news about NEPI ROCKCASTLE.
7. VIVORYON (VVY.AS)
-7.01% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON dropping 7.01% to €17.78 on Thursday while AEX-Index rose 0.38% to €751.12.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-0.65.
Volatility
VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was 3.79%, 1.49%, and 2.77%.
VIVORYON’s highest amplitude of average volatility was 4.47% (last week), 2.94% (last month), and 2.77% (last quarter).
More news about VIVORYON.
8. CROSSWOOD (CROS.PA)
-6.76% Price Change
Crosswood SA engages in real estate activity in France. Its property portfolio includes shops and offices, and housing properties. The company was formerly known as Desquenne et Giral. Crosswood SA was incorporated in 1935 and is based in Paris, France. Crosswood SA operates as a subsidiary of Compagnie Financiere De Broceliande.
CAC 40 ended the session with CROSSWOOD dropping 6.76% to €13.80 on Thursday while CAC 40 rose 0.28% to €7,381.78.
Earnings Per Share
As for profitability, CROSSWOOD has a trailing twelve months EPS of €0.57.
PE Ratio
CROSSWOOD has a trailing twelve months price to earnings ratio of 24.21. Meaning, the purchaser of the share is investing €24.21 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.48%.
Moving Average
CROSSWOOD’s value is way higher than its 50-day moving average of €8.67 and way higher than its 200-day moving average of €8.04.
More news about CROSSWOOD.
9. ALFEN (ALFEN.AS)
-5.96% Price Change
Alfen N.V., through its subsidiaries, designs, engineers, develops, produces, and sells products, systems, and services related to the electricity grid. The company offers smart grid solutions, including secondary transformer substations for grid operators, devices for grid automation, and proprietary back-end systems for remote management and control of electricity grids, as well as micro-grids; and supplementary offerings to grid connect amongst others PV farms, EV fast-charging hubs, and industrial companies. It also provides energy storage systems comprising stationary and mobile battery energy storage solutions for load balancing, peak shaving, grid frequency control, and energy trading solutions, as well as embedded software and back-office solutions that enables remote monitoring, control, and support for storage applications. In addition, the company offers smart and connected electric vehicle chargers for use at the home, retail, workplace, and public locations, as well as an online management platform for charging infrastructure and standardized solutions for smart charging, load balancing, charging hubs, and plug and charge functionalities. It operates primarily in the Netherlands, Belgium, Finland, France, Germany, Italy, Norway, Poland, Spain, Sweden, Switzerland, Austria, the United Kingdom, and the rest of Europe. The company was founded in 1937 and is headquartered in Almere, the Netherlands.
AEX-Index ended the session with ALFEN falling 5.96% to €72.86 on Thursday while AEX-Index rose 0.38% to €751.12.
Earnings Per Share
As for profitability, ALFEN has a trailing twelve months EPS of €2.5.
PE Ratio
ALFEN has a trailing twelve months price to earnings ratio of 29.14. Meaning, the purchaser of the share is investing €29.14 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.97%.
Sales Growth
ALFEN’s sales growth for the current quarter is 50.5%.
Yearly Top and Bottom Value
ALFEN’s stock is valued at €72.86 at 22:40 EST, way under its 52-week high of €120.80 and higher than its 52-week low of €68.70.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALFEN’s stock is considered to be overbought (>=80).
More news about ALFEN.
10. PETROLIA (PSE.OL)
-5.67% Price Change
Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.
Oslo Børs Benchmark Index_GI ended the session with PETROLIA falling 5.67% to €3.66 on Thursday while Oslo Børs Benchmark Index_GI slid 0.21% to €1,201.49.
Earnings Per Share
As for profitability, PETROLIA has a trailing twelve months EPS of kr-0.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.9%.
Moving Average
PETROLIA’s value is under its 50-day moving average of kr4.05 and way under its 200-day moving average of kr4.62.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 55.5M for the twelve trailing months.
Volume
Today’s last reported volume for PETROLIA is 2522 which is 86.4% below its average volume of 18550.
Volatility
PETROLIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.66%, a negative 0.05%, and a positive 3.08%.
PETROLIA’s highest amplitude of average volatility was 4.02% (last week), 3.03% (last month), and 3.08% (last quarter).
More news about PETROLIA.
Stay up to date with our winners and losers daily report
